Loading…

Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage

Background Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may c...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric pulmonology 2020-10, Vol.55 (10), p.2737-2741
Main Authors: Joseph, Leon, Goldberg, Shmuel, Cohen, Shlomo, Picard, Elie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3
cites cdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3
container_end_page 2741
container_issue 10
container_start_page 2737
container_title Pediatric pulmonology
container_volume 55
creator Joseph, Leon
Goldberg, Shmuel
Cohen, Shlomo
Picard, Elie
description Background Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB). Research Question To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB. Study Design and Methods Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever. Results Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35). Conclusion FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.
doi_str_mv 10.1002/ppul.24992
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2428415861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2442594400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</originalsourceid><addsrcrecordid>eNp90MtOGzEUBmCratWE0A0PgEbqBiENHF_mtkSoLUiRYFHWI499nEzk2IOdCcquj8Az9klqSMqCBasj2Z9_-fyEnFC4oADschhGe8FE07BPZEqhaXIQTfmZTOuqKPKyLvmEHMW4Akh3Df1KJpxVrGgKMSXdbTcOwRt0mfYYM-c32RBwiy5NHzdd8E4tfVR-2GUmnYesd5la9laH9GZ0GsPC926RHeTfP8_SbtFbGTIrt3KBx-SLkTbit8OckYefP35f3-Tzu1-311fzXPGiYrmpas4bwaVWqgZmsOKs5MKABs0pGNRCYqexVKqrOJQaJYCqFFegO1UbPiNn-9y0z-OIcdOu-6jQWunQj7FlgtWCFnVJE_3-jq78GFz6XVIiVSMEQFLne6WCjzGgaYfQr2XYtRTal-bbl-bb1-YTPj1Ejt0a9Rv9X3UCdA-eeou7D6La-_uH-T70HwQ4kdc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442594400</pqid></control><display><type>article</type><title>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</title><source>Wiley</source><creator>Joseph, Leon ; Goldberg, Shmuel ; Cohen, Shlomo ; Picard, Elie</creator><creatorcontrib>Joseph, Leon ; Goldberg, Shmuel ; Cohen, Shlomo ; Picard, Elie</creatorcontrib><description>Background Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB). Research Question To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB. Study Design and Methods Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever. Results Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35). Conclusion FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.24992</identifier><identifier>PMID: 32725954</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Bronchoalveolar Lavage - adverse effects ; Bronchoscopy ; Bronchoscopy - adverse effects ; Child ; Child, Preschool ; children ; Double-Blind Method ; Female ; fever ; Fever - drug therapy ; Humans ; ibuprofen ; Ibuprofen - therapeutic use ; Infant ; Lavage ; Male ; Nonsteroidal anti-inflammatory drugs ; Pediatrics ; Treatment Outcome</subject><ispartof>Pediatric pulmonology, 2020-10, Vol.55 (10), p.2737-2741</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</citedby><cites>FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</cites><orcidid>0000-0003-4037-0447 ; 0000-0001-6796-3459 ; 0000-0002-2891-642X ; 0000-0003-0235-0779</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32725954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joseph, Leon</creatorcontrib><creatorcontrib>Goldberg, Shmuel</creatorcontrib><creatorcontrib>Cohen, Shlomo</creatorcontrib><creatorcontrib>Picard, Elie</creatorcontrib><title>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</title><title>Pediatric pulmonology</title><addtitle>Pediatr Pulmonol</addtitle><description>Background Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB). Research Question To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB. Study Design and Methods Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever. Results Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35). Conclusion FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Bronchoalveolar Lavage - adverse effects</subject><subject>Bronchoscopy</subject><subject>Bronchoscopy - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>children</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>fever</subject><subject>Fever - drug therapy</subject><subject>Humans</subject><subject>ibuprofen</subject><subject>Ibuprofen - therapeutic use</subject><subject>Infant</subject><subject>Lavage</subject><subject>Male</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Pediatrics</subject><subject>Treatment Outcome</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp90MtOGzEUBmCratWE0A0PgEbqBiENHF_mtkSoLUiRYFHWI499nEzk2IOdCcquj8Az9klqSMqCBasj2Z9_-fyEnFC4oADschhGe8FE07BPZEqhaXIQTfmZTOuqKPKyLvmEHMW4Akh3Df1KJpxVrGgKMSXdbTcOwRt0mfYYM-c32RBwiy5NHzdd8E4tfVR-2GUmnYesd5la9laH9GZ0GsPC926RHeTfP8_SbtFbGTIrt3KBx-SLkTbit8OckYefP35f3-Tzu1-311fzXPGiYrmpas4bwaVWqgZmsOKs5MKABs0pGNRCYqexVKqrOJQaJYCqFFegO1UbPiNn-9y0z-OIcdOu-6jQWunQj7FlgtWCFnVJE_3-jq78GFz6XVIiVSMEQFLne6WCjzGgaYfQr2XYtRTal-bbl-bb1-YTPj1Ejt0a9Rv9X3UCdA-eeou7D6La-_uH-T70HwQ4kdc</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Joseph, Leon</creator><creator>Goldberg, Shmuel</creator><creator>Cohen, Shlomo</creator><creator>Picard, Elie</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4037-0447</orcidid><orcidid>https://orcid.org/0000-0001-6796-3459</orcidid><orcidid>https://orcid.org/0000-0002-2891-642X</orcidid><orcidid>https://orcid.org/0000-0003-0235-0779</orcidid></search><sort><creationdate>202010</creationdate><title>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</title><author>Joseph, Leon ; Goldberg, Shmuel ; Cohen, Shlomo ; Picard, Elie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Bronchoalveolar Lavage - adverse effects</topic><topic>Bronchoscopy</topic><topic>Bronchoscopy - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>children</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>fever</topic><topic>Fever - drug therapy</topic><topic>Humans</topic><topic>ibuprofen</topic><topic>Ibuprofen - therapeutic use</topic><topic>Infant</topic><topic>Lavage</topic><topic>Male</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Pediatrics</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joseph, Leon</creatorcontrib><creatorcontrib>Goldberg, Shmuel</creatorcontrib><creatorcontrib>Cohen, Shlomo</creatorcontrib><creatorcontrib>Picard, Elie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joseph, Leon</au><au>Goldberg, Shmuel</au><au>Cohen, Shlomo</au><au>Picard, Elie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr Pulmonol</addtitle><date>2020-10</date><risdate>2020</risdate><volume>55</volume><issue>10</issue><spage>2737</spage><epage>2741</epage><pages>2737-2741</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><abstract>Background Fiber‐optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB). Research Question To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB. Study Design and Methods Children presenting for elective FOB and broncho‐alveolar lavage (BAL) were randomized, in a double‐blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever. Results Sixty‐one children were included in the final analysis. Thirty‐one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35). Conclusion FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti‐inflammatory drug ibuprofen administered before a FOB does not prevent FPB.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32725954</pmid><doi>10.1002/ppul.24992</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4037-0447</orcidid><orcidid>https://orcid.org/0000-0001-6796-3459</orcidid><orcidid>https://orcid.org/0000-0002-2891-642X</orcidid><orcidid>https://orcid.org/0000-0003-0235-0779</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 8755-6863
ispartof Pediatric pulmonology, 2020-10, Vol.55 (10), p.2737-2741
issn 8755-6863
1099-0496
language eng
recordid cdi_proquest_miscellaneous_2428415861
source Wiley
subjects Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Bronchoalveolar Lavage - adverse effects
Bronchoscopy
Bronchoscopy - adverse effects
Child
Child, Preschool
children
Double-Blind Method
Female
fever
Fever - drug therapy
Humans
ibuprofen
Ibuprofen - therapeutic use
Infant
Lavage
Male
Nonsteroidal anti-inflammatory drugs
Pediatrics
Treatment Outcome
title Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho‐alveolar lavage
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A59%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ibuprofen%20does%20not%20prevent%20postbronchoscopy%20fever%20in%20children%20undergoing%20broncho%E2%80%90alveolar%20lavage&rft.jtitle=Pediatric%20pulmonology&rft.au=Joseph,%20Leon&rft.date=2020-10&rft.volume=55&rft.issue=10&rft.spage=2737&rft.epage=2741&rft.pages=2737-2741&rft.issn=8755-6863&rft.eissn=1099-0496&rft_id=info:doi/10.1002/ppul.24992&rft_dat=%3Cproquest_cross%3E2442594400%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3572-f7833943adcc802fe732634f0d0d310fed4aebde6ccb7306dea00c7c3c0dbc8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2442594400&rft_id=info:pmid/32725954&rfr_iscdi=true